Resynthesis Sample Clauses

Resynthesis. ArQule shall resynthesize and deliver to SB an additional quantity of any Available Compound requested by SB to enable SB to conduct screening activities. The Available Compounds may come from the Compass Array Library or a Mapping Array Library. SB shall provide ArQule with written notice of the Available Compounds that SB desires to have resynthesized by ArQule, in accordance with the specifications set forth in Schedule A. In each case the amount of, and delivery schedule for, resynthesized Available Compounds will be determined by SB, subject to approval by the JSC.
Sample 1Sample 2
AutoNDA by SimpleDocs
Resynthesis. During the period from [*****] ArQule shall resynthesize and deliver to Sankyo an additional [*****] of any Available Compound requested by Sankyo to enable Sankyo to conduct confirmatory screening activities. Sankyo shall provide ArQule with written notice of the Available Compounds that Sankyo desires to have resynthesized by ArQule, in accordance with the specifications set forth in EXHIBIT A. In each case the actual amount of, and delivery schedule for, resynthesized Available Compounds will be determined by the Research Committee. ArQule will continue to reserve all of the Available Compounds from the same Mapping Array Library for a period [*****] after Sankyo receives at least one resynthesized Available Compound from that Mapping Array Library. The Steering Committee may extend this reservation period for one or more Available Compounds.
Sample 1
Resynthesis. During the Research Period, ArQule shall resynthesize and deliver to Solvay an additional [*****] mg quantity of any Available Compound requested by Solvay to enable Solvay to conduct confirmatory screening activities. Solvay shall provide ArQule with written notice of the Available Compounds that Solvay desires to have resynthesized by ArQule. ArQule shall resynthesize the requested compounds in accordance with the specifications set forth in Exhibit A. In each case the actual amount of, and delivery schedule for, resynthesized Available Compounds will be determined by the Research Committee. ArQule will maintain the reservation on each group of Available Compounds (as determined by the Research Committee under Section 3.4.) while ArQule prepares resynthesis quantities of selected Available Compounds from that group and will then continue to reserve that group of Available Compound
Sample 1
Resynthesis. During the Research Period, ArQule shall resynthesize and deliver to Solvay an additional 25 mg quantity of any Available Compound requested by Solvay to enable Solvay to conduct confirmatory screening activities. Solvay shall provide ArQule with written notice of the Available Compounds that Solvay desires to have resynthesized by ArQule. ArQule shall resynthesize the requested compounds in accordance with the specifications set forth in Exhibit A. In each case the actual amount of, and delivery schedule for, resynthesized Available Compounds will be determined by the Research Committee. ArQule will maintain the reservation on each group of Available Compounds (as determined by the Research Committee under Section 3.4.) while ArQule prepares resynthesis quantities of selected Available Compounds from that group and will then continue to reserve that group of Available Compound for a period of up to three (3) months after Solvay receives the resynthesized Available Compounds.
Sample 1
Resynthesis. During the period from the Effective Date through March 31, 2003, ArQule shall resynthesize and deliver to Sankyo an adxxxxxxxx 0 xx xxxxxxxx of any Available Compound requested by Sankyo to enable Sankyo to conduct confirmatory screening activities. Sankyo shall provide ArQule with written notice of the Available Compounds that Sankyo desires to have resynthesized by ArQule, in accordance with the specifications set forth in Exhibit A. In each case the actual amount of, and delivery schedule for, resynthesized Available Compounds will be determined by the Research Committee. ArQule will continue to reserve all of the Available Compounds from the same Mapping Array Library for a period of ninety (90) days after Sankyo receives at least one resynthesized Available Compound from that Mapping Array Library. The Steering Committee may extend this reservation period for one or more Available Compounds.
Sample 1

Related to Resynthesis

  • Manufacturing (a) The Supplier shall without limitation be responsible, at no additional cost to the Purchaser, for: sourcing and procuring all raw materials for the Products; obtaining all necessary approvals, permits and licenses for the manufacturing of the Products; providing sufficient qualified staff and workers to perform the obligations under this Purchase Agreement; implementing and maintaining effective inventory and production control procedures with respect to the Products; and handling other matters as reasonably requested by the Purchaser from time to time. (b) The Supplier shall not change any process, material, component, packaging or manufacturing location without the Purchaser’s express prior written approval.

  • Fabrication Making up data or results and recording or reporting them.

  • Laboratory Testing All laboratories selected by UPS Freight for analyzing Controlled Substances Testing will be HHS certified.

  • Screening After you sign and date the consent document, you will begin screening. The purpose of the screening is to find out if you meet all of the requirements to take part in the study. Procedures that will be completed during the study (including screening) are described below. If you do not meet the requirements, you will not be able to take part in the study. The study investigator or study staff will explain why. As part of screening, you must complete all of the items listed below: • Give your race, age, gender, and ethnicity • Give your medical history o You must review and confirm the information in your medical history questionnaire • Give your drug, alcohol, and tobacco use history • Give your past and current medication and treatment history. This includes any over-the-counter or prescription drugs, such as vitamins, dietary supplements, or herbal supplements, taken in the past 28 days • Height and weight will be measured • Physical exam will be done • Electrocardiogram (ECG) will be collected. An ECG measures the electrical activity of the heart • You may be tested for COVID-19 o Blood tests for human immunodeficiency virus (HIV), hepatitis B, and hepatitis C o Blood tests to see how your blood clots ▪ Fibrinogen ▪ PT/INR/aPTT o Blood tests for amylase and lipase (enzymes that help with digestion, Part B only) o Blood tests for a lipid (fats) panel (Part B only) ▪ Total cholesterol ▪ Triglycerides ▪ HDL ▪ Direct HDL o Blood tests to check your thyroid function (Part B and Part C only) ▪ TSH ▪ Free T4 o Urine to test for drugs of abuse (illegal and prescription) o Urine tests to check your albumin/ creatinine ratio o Females who have not had a period for at least 12 months in a row will have a blood hormone test to confirm they cannot have children • The study investigator may decide to do an alcohol breath test • The use of proper birth control will be reviewed (males only) • You will be asked “How do you feel?” HIV, hepatitis B, and hepatitis C will be tested at screening. If anyone is exposed to your blood during the study, you will have these tests done again. If you have a positive test, you cannot be in or remain in the study. HIV is the virus that causes acquired immunodeficiency syndrome (AIDS). If your HIV test is positive, you will be told about the results. It may take weeks or months after being infected with HIV for the test to be positive. The HIV test is not always right. Having certain infections or positive test results may have to be reported to the State Department of Health. This includes results for HIV, hepatitis, and other infections. If you have any questions about what information is required to be reported, please ask the study investigator or study staff. Although this testing is meant to be private, complete privacy cannot be guaranteed. For example, it is possible for a court of law to get health or study records without your permission.

  • Solution The Supplier’s contractually committed technical approach for solving an information technology business objective and associated Requirements as defined and authorized by the scope of the Contract or any order or Statement of Work issued under the Contract. Solution means all Supplier and Supplier’s third-party providers’ components making up the Solution, including but not limited to Software, Product, configuration design, implementation, Supplier-developed interfaces, Services and Work Product.

  • Diagnostic procedures to aid the Provider in determining required dental treatment.

  • Speech Therapy This plan covers speech therapy services when provided by a qualified licensed • loss of speech or communication function; or • impairment as a result of an acute illness or injury, or an acute exacerbation of a chronic disease. Speech therapy services must relate to: • performing basic functional communication; or • assessing or treating swallowing dysfunction. See Autism Services when speech therapy services are rendered as part of the treatment of autism spectrum disorder. The amount you pay and any benefit limit will be the same whether the services are provided for habilitative or rehabilitative purposes.

  • Human Leukocyte Antigen Testing This plan covers human leukocyte antigen testing for A, B, and DR antigens once per member per lifetime to establish a member’s bone marrow transplantation donor suitability in accordance with R.I. General Law §27-20-36. The testing must be performed in a facility that is: • accredited by the American Association of Blood Banks or its successors; and • licensed under the Clinical Laboratory Improvement Act as it may be amended from time to time. At the time of testing, the person being tested must complete and sign an informed consent form that also authorizes the results of the test to be used for participation in the National Marrow Donor program.

  • RE-WEIGHING PRODUCT Deliveries are subject to re- weighing at the point of destination by the Authorized User. If shrinkage occurs which exceeds that normally allowable in the trade, the Authorized User shall have the option to require delivery of the difference in quantity or to reduce the payment accordingly. Such option shall be exercised in writing by the Authorized User.

  • Drug Testing (A) The state and the PBA agree to drug testing of employees in accordance with section 112.0455, F.S., the Drug-Free Workplace Act. (B) All classes covered by this Agreement are designated special risk classes for drug testing purposes. Special risk means employees who are required as a condition of employment to be certified under Chapter 633 or Chapter 943, F.S. (C) An employee shall have the right to grieve any disciplinary action taken under section 112.0455, the Drug-Free Workplace Act, subject to the limitations on the grievability of disciplinary actions in Article 10. If an employee is not disciplined but is denied a demotion, reassignment, or promotion as a result of a positive confirmed drug test, the employee shall have the right to grieve such action in accordance with Article 6.

Draft better contracts in just 5 minutes Get the weekly Law Insider newsletter packed with expert videos, webinars, ebooks, and more!